Journal article
Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategies
Medical oncology (Northwood, London, England), Vol.41(2), p.51
01/09/2024
DOI: 10.1007/s12032-023-02280-7
PMID: 38195781
Abstract
Cancer, characterized by the uncontrolled proliferation of aberrant cells, underscores the imperative for innovative therapeutic approaches. Immunotherapy has emerged as a pivotal constituent in cancer treatment, offering improved prognostic outcomes for a substantial patient cohort. Noteworthy for its precision, immunotherapy encompasses strategies such as adoptive cell therapy and checkpoint inhibitors, orchestrating the immune system to recognize and selectively target malignant cells. Exploiting the specificity of the immune response renders immunotherapy efficacious, as it selectively targets the body's immune milieu. Diverse mechanisms underlie cancer immunotherapies, leading to distinct toxicity profiles compared to conventional treatments. A remarkable clinical stride in the anticancer resources is immunotherapy. Remarkably, certain recalcitrant cancers like skin malignancies exhibit resistance to radiation or chemotherapy, yet respond favorably to immunotherapeutic interventions. Notably, combination therapies involving chemotherapy and immunotherapy have exhibited synergistic effects, enhancing overall therapeutic efficacy. Understanding the pivotal role of immunotherapy elucidates its complementary value, bolstering the therapeutic landscape. In this review, we elucidate the taxonomy of cancer immunotherapy, encompassing adoptive cell therapy and checkpoint inhibitors, while scrutinizing their distinct adverse event profiles. Furthermore, we expound on the unprecedented potential of immunogenic vaccines to bolster the anticancer immune response. This comprehensive analysis underscores the significance of immunotherapy in modern oncology, unveiling novel prospects for tailored therapeutic regimens.
Details
- Title: Subtitle
- Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategies
- Creators
- Neha R. Raghani - Gujarat UniversityMehul R. Chorawala - Gujarat UniversityMayuresh Mahadik - Ganpat UniversityRakesh B. Patel - University of IowaBhupendra G. Prajapati - Ganpat UniversityPriyajeet S. Parekh - AV Pharm LLC, 1545 Univ Blvd N Ste A, Jacksonville, FL 32211 USA
- Resource Type
- Journal article
- Publication Details
- Medical oncology (Northwood, London, England), Vol.41(2), p.51
- DOI
- 10.1007/s12032-023-02280-7
- PMID
- 38195781
- ISSN
- 1357-0560
- eISSN
- 1559-131X
- Publisher
- Humana Press Inc
- Number of pages
- 20
- Grant note
- Ganpat University
- Language
- English
- Date published
- 01/09/2024
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985132075402771
Metrics
1 Record Views